Medtronic to present data on Micra transcathter pacing system to FDA committee

Medtronic will present data on its Micra Transcatheter Pacing System to an FDA advisory committee on Feb. 18. The Micra, a miniature leadless pacemaker, is not yet FDA-approved.

In November, results of a trial evaluating the Micra were presented at the American Heart Association Scientific Sessions and simultaneously published online in the New England Journal of Medicine. At the time, Medtronic said it expected to hear about an FDA approval during fiscal year 2017, which begins in May 2016.

After six months of implantation with the Micra, 96 percent of patients did not have system-related or procedure-related major complications and 98.3 percent of the patients had a low and stable pacing capture threshold. In addition, the device was successfully implanted in 99.2 percent of patients.

On Feb. 18, Medtronic will present data in front of the FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee. The meeting, which is open to the public, will take place at the Hilton Washington DC North hotel Gaithersburg, Md.

“The Committee will discuss and make recommendations on clinical trial, postapproval study design, and physician training requirements for leadless cardiac pacemaker device technology,” the committee said in a posting on its website. “Specifically, the Committee will be asked to make recommendations on the acceptability of adverse event rates in acute and chronic timeframes as well as indications for use for this device type, given availability of other technologies with different adverse event profiles; required training and acceptability of observed learning curves for the new device type and necessary elements for postapproval study collection.”

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."